Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

There is considerable variation in specialty drug coverage across commercial health plans

Variation in Specialty Drug Coverage Across Health Plans

Plans restrict coverage of drugs indicated for cancer less often than drugs indicated for other diseases
Ritonavir-boosted protease inhibitor therapy is associated with worse outcomes

Protease Inhibitors May Worsen Outcomes for HIV + Heart Failure

Higher rates seen for hyperlipidemia, diabetes, coronary artery disease, cardiovascular mortality
Tamsulosin does not significantly increase the urinary stone passage rate compared with placebo

Tamsulosin Does Not Appear to Promote Urinary Stone Passage

Findings do not support tamsulosin treatment for symptomatic urinary stones <9 mm
In a report published online July 31 in the Annals of Internal Medicine

Rapid Improvement of Dilated Cardiomyopathy With Anakinra

Patient's clinical symptoms related to heart failure improved markedly within two weeks of treatment
Acupuncture may cut joint pain among postmenopausal women with early-stage breast cancer and aromatase inhibitor-related pain

Acupuncture May Cut Arthralgia From Aromatase Inhibitors

Clinical significance of the pain reduction remains uncertain

American Association of Colleges of Pharmacy, July 21-25

The American Association of Colleges of Pharmacy The annual meeting of the American Association of Colleges of Pharmacy was held from July 21...
In recent years there have been low rates of osteoporosis treatment initiation after a hip fracture

Drop in Osteoporosis Treatment Initiation After Hip Fracture

Adherence to regimen needed to cut subsequent fracture risk
An experimental drug appears to slow mental decline by as much as 30 percent in Alzheimer's disease patients

Experimental Drug Slows Mental Decline in Alzheimer’s Patients

However, the Phase 2 study of BAN2401 did not meet its primary end point
For patients younger than 60 years who have had a cryptogenic ischemic stroke thought to be secondary to patent foramen ovale (PFO)

PFO Closure Plus Antiplatelet Tx Advised for Cryptogenic Stroke

PFO closure plus antiplatelets recommended over antiplatelet therapy alone for patients <60 years
A small-molecule inhibitor of plasma kallikrein

Daily BCX7353 Cuts Rate of Hereditary Angioedema Attacks

Oral administration of BCX7353 at dose of ≥125 mg results in lower rate of attacks versus placebo